Tag Archives: SAVA

Fraud Allegations Are Unlikely to Keep Cassava Stock Down

Allegations of fraud against Cassava Sciences (NASDAQ:SAVA) are unlikely to stop its Alzheimer’s drug candidate from quickly advancing to a Phase 3 clinical trial. As a result, I remain very bullish on SAVA stock.

Source: Shutterstock

One of the most important reasons is an issue that hasn’t been explored very much yet. Specifically, none of the allegations against Cassava relates directly to the most recent safety and cognition data on its Alzheimer candidate, simufilam.

That safety and cognition data, released on July 29, was incredibly positive, as simufilam....More>>>

Best Insurance Stocks To Invest In 2023

Cigna Corp. (CI Quick QuoteCI ) has announced an expansion of its plan offerings on the Affordable Care Act’s insurance exchanges, branching out into additional counties across three states for 2022.

The expansion brings the total number of states offering Cigna ACA plans to 13 in 313 counties.

Cigna is already one of the top providers of ACA plans, other companies being UnitedHealth Group Inc. (UNH Quick QuoteUNH ) , Centene Corp. (CNC Quick QuoteCNC ) , Molina Healthcare, Inc. (MOH Quick QuoteMOH ) among others.

Earlier this month, another health insurer....More>>>